• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Wave tanks again as Huntington's clinical trial data underwhelm

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 02, 2020 at 11:12: AM
via Data from a phase 1b/2a trial have raised doubts about whether Wave Life Sciences’ Huntington’s disease drug can compete with Roche and Ionis’ rival candidate. The results wiped 50% off Wave’s share price, adding to losses it suffered when it dumped a Duchenne muscular dystrophy (DMD) program earlier in December.

article source
 




Top Bottom
Back
Quote